first glp 1 drug The FDA has approved the pill version of GLP-1 drugs. Novo Nordisk says participants who took the Wegovy pill in clinical trials lost an average of 16.6% of their body weight Wegovy Pill Wins FDA Approval

There has been a sharp rise in GLP-1 prescriptions in recent years

Type 3 diabetes is a term used to underscore a growing body of evidence that Alzheimers involves insulin resistance in the brain, impaired glucose metabolism, mitochondrial dysfunction, chronic inflammation, and oxidative stressmuch like in type 2 diabetes

However, enthusiasm for it has been declining, as outcomes in earlier reports have not been replicated in newer ones

This change in digestion speed can lead to common potential side effects like nausea, bloating, and constipation

Both tirzepatide and semaglutide injections have been shown to reduce weight in patients with overweight or obesity in randomized controlled trials